Back to News
Market Impact: 0.65

Nvidia says U.S. government will allow it to resume H20 AI chip sales to China

NVDA
Artificial IntelligenceTechnology & InnovationSanctions & Export ControlsTrade Policy & Supply ChainElections & Domestic PoliticsCompany Fundamentals
Nvidia says U.S. government will allow it to resume H20 AI chip sales to China

Nvidia announced it expects to resume sales of its H20 GPUs to China, citing U.S. government assurances of license grants. This follows a preliminary U.S.-China trade deal and intensive lobbying by CEO Jensen Huang, who recently met with President Trump and Chinese officials, arguing that export controls had significantly cut Nvidia's China market share. The resumption, alongside the introduction of a new "fully compliant" RTX PRO GPU, signals a potential easing of tech export restrictions and a strategic move to regain market presence in China.

Analysis

Nvidia is poised to resume sales of its H20 GPUs to China following assurances from the U.S. government that export licenses will be granted, reversing a sales halt that began in April. This development appears to be a direct result of high-level corporate diplomacy, including CEO Jensen Huang's recent meeting with President Trump and ongoing visit to China, and is set against the backdrop of a preliminary U.S.-China trade agreement. The strategic importance of this reversal is underscored by Huang's prior statement that restrictions had cut Nvidia's China market share by nearly half, making the resumption critical for recovering lost ground. In a parallel strategic move, the company has also announced a new "fully compliant" NVIDIA RTX PRO GPU, targeting industrial applications like digital twin AI. This dual approach of seeking license approvals for existing chips while developing new compliant products demonstrates a multi-faceted strategy to navigate and mitigate the impact of U.S. export controls, a development viewed with strong optimism as reflected by the high sentiment scores.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo